3,818
Views
0
CrossRef citations to date
0
Altmetric
Review Article

The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance in acne management

&
Article: 2296855 | Received 29 Oct 2023, Accepted 14 Dec 2023, Published online: 26 Dec 2023

References

  • Costa CS, Bagatin E, Yang Z, et al. Systemic pharmacological treatments for acne: an overview of systematic reviews (protocol). Cochrane Database Syst Rev. 2021;2021(11):1.
  • Leung AK, Barankin B, Lam JM, et al. Dermatology: how to manage acne vulgaris. Drugs Context. 2021;10:2021-8-6. doi: 10.7573/dic.2021-8-6.
  • Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2163–8. doi: 10.1016/S0140-6736(12)61729-2.
  • Lynn DD, Umari T, Dunnick CA, et al. The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther. 2016;7:13–25. doi: 10.2147/AHMT.S55832.
  • Layton AM, Thiboutot D, Tan J. Reviewing the global burden of acne: how could we improve care to reduce the burden? Br J Dermatol. 2021;184(2):219–225. doi: 10.1111/bjd.19477.
  • Baldwin H, Farberg A, Frey C, et al. Unmet needs in the management of acne vulgaris: a consensus statement. J Drugs Dermatol. 2023;22(6):582–587. doi: 10.36849/JDD.7587.
  • Zouboulis CC, Piquero-Martin J. Update and future of systemic acne treatment. Dermatology. 2003;206(1):37–53. doi: 10.1159/000067821.
  • Del Rosso JQ, Kircik LH, Stein Gold L, et al. Androgens, androgen receptors, and the skin: from the laboratory to the clinic with emphasis on clinical and therapeutic implications. J Drugs Dermatol. 2020;19(3):30–35.
  • Elsaie ML. Hormonal treatment of acne vulgaris: an update. Clin Cosmet Investig Dermatol. 2016;9:241–248. doi: 10.2147/CCID.S114830.
  • Dudhat S, Singh P, Pimple P. Insights of lipid vesicular and particulate carrier mediated approach for acne management. Curr Drug Deliv. 2022;20(1):57–74. doi: 10.2174/1567201819666220524154448.
  • Cunliffe WJ. Androgen abnormalities in acne subjects. In: Acne. London (UK): Martin Dunitz Ltd; 1989.
  • Nelson AT. Sebum. In: Shalita AR, Del Rosso JQ, Webster GF, editors. Acne vulgaris. London (UK): Informa Healthcare; 2011.
  • Camera E, Ludovici M, Tortorella S, et al. Use of lipidomics to investigate sebum dysfunction in juvenile acne. J Lipid Res. 2016;57(6):1051–1058. doi: 10.1194/jlr.M067942.
  • Pappas A, Johnsen S, Liu JC, et al. Sebum analysis of individuals with and without acne. Dermatoendocrinol. 2009;1(3):157–161. doi: 10.4161/derm.1.3.8473.
  • Smith RN, Braue A, Varigos GA, et al. The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides. J Dermatol Sci. 2008;50(1):41–52. doi: 10.1016/j.jdermsci.2007.11.005.
  • Cao K, Liu Y, Liang N, et al. Fatty acid profiling in facial sebum and erythrocytes from adult patients with moderate acne. Front Physiol. 2022;13:921866. doi: 10.3389/fphys.2022.921866.
  • Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–973 e33. doi: 10.1016/j.jaad.2015.12.037.
  • YAZ® (Drospirenone and ethinyl estradiol) tablets [prescribing information]. Whippany (NJ): Bayer HealthCare Pharmaceuticals Inc; 2023.
  • BEYAZ® (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets), for oral use [prescribing information]. Whippany (NJ): Bayer HealthCare Pharmaceuticals Inc.; 2023.
  • Aldactone® (spironolactone) tablets, for oral use [prescribing information]. New York (NY): Pfizer Labs; 2022.
  • ACCUTANE® (isotretinoin) [prescribing information]. Nutley (NJ): Roche Laboratories Inc.; 2008.
  • Zouboulis CC, Coenye T, He L, et al. Sebaceous immunobiology – skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations. Front Immunol. 2022;13:1029818. doi: 10.3389/fimmu.2022.1029818.
  • Podgórska A, Puścion-Jakubik A, Markiewicz-Żukowska R, et al. Acne vulgaris and intake of selected dietary nutrients-a summary of information. Healthcare (Basel). 2021;9(6):668. doi: 10.3390/healthcare9060668.
  • Hoover E, Aslam S, Krishnamurthy K. Physiology, sebaceous glands. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
  • Zouboulis CC. Endocrinology and immunology of acne: two sides of the same coin. Exp Dermatol. 2020;29(9):840–859. doi: 10.1111/exd.14172.
  • Plewig G, Kligman AM. Proliferative activity of the sebaceous glands of the aged. J Invest Dermatol. 1978;70(6):314–317. doi: 10.1111/1523-1747.ep12543478.
  • Pochi PE, Strauss JS, Downing DT. Age-related changes in sebaceous gland activity. J Invest Dermatol. 1979;73(1):108–111. doi: 10.1111/1523-1747.ep12532792.
  • Yamamoto A, Ito M. Sebaceous gland activity and urinary androgen levels in children. J Dermatol Sci. 1992;4(2):98–104. doi: 10.1016/0923-1811(92)90066-k.
  • Pochi PE, Strauss JS, Downing DT. Skin surface lipid composition, acne, pubertal development, and urinary excretion of testosterone and 17-ketosteroids in children. J Invest Dermatol. 1977;69(5):485–489. doi: 10.1111/1523-1747.ep12511753.
  • Ottaviani M, Camera E, Picardo M. Lipid mediators in acne. Mediators Inflamm. 2010;2010:858176. doi: 10.1155/2010/858176.
  • Akamatsu H, Zouboulis CC, Orfanos CE. Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol. 1992;99(4):509–511. doi: 10.1111/1523-1747.ep12616181.
  • Sato T, Imai N, Akimoto N, et al. Epidermal growth factor and 1alpha,25-dihydroxyvitamin D3 suppress lipogenesis in hamster sebaceous gland cells in vitro. J Invest Dermatol. 2001;117(4):965–970. doi: 10.1046/j.0022-202x.2001.01516.x.
  • Tsukada M, Schröder M, Roos TC, et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol. 2000;115(2):321–327. doi: 10.1046/j.1523-1747.2000.00066.x.
  • Hong I, Lee MH, Na TY, et al. LXRalpha enhances lipid synthesis in SZ95 sebocytes. J Invest Dermatol. 2008;128(5):1266–1272. doi: 10.1038/sj.jid.5701134.
  • Rosenfield RL, Deplewski D, Kentsis A, et al. Mechanisms of androgen induction of sebocyte differentiation. Dermatology. 1998;196(1):43–46. doi: 10.1159/000017864.
  • Fischer H, Fumicz J, Rossiter H, et al. Holocrine secretion of sebum is a unique DNASE2-dependent mode of programmed cell death. J Invest Dermatol. 2017;137(3):587–594. doi: 10.1016/j.jid.2016.10.017.
  • Jung Y, Tam J, Ray Jalian H, et al. Longitudinal, 3D in vivo imaging of sebaceous glands by coherent anti-stokes Raman scattering microscopy: normal function and response to cryotherapy. J Invest Dermatol. 2015;135(1):39–44. doi: 10.1038/jid.2014.293.
  • Plewig G, Christophers E. Renewal rate of human sebaceous glands. Acta Derm Venereol. 1974;54(3):177–182. doi: 10.2340/0001555554177182.
  • Harding CR. The stratum corneum: structure and function in health and disease. Dermatol Ther. 2004;17(Suppl 1):6–15. doi: 10.1111/j.1396-0296.2004.04s1001.x.
  • Greene RS, Downing DT, Pochi PE, et al. Anatomical variation in the amount and composition of human skin surface lipid. J Invest Dermatol. 1970;54(3):240–247. doi: 10.1111/1523-1747.ep12280318.
  • Cunliffe WJ. Biochemistry of the pilosebaceous unit. In: Acne. London (UK): Martin Dunitz Ltd; 1989.
  • Cunliffe WJ. Sebaceous gland physiology. In: Acne. London (UK): Martin Dunitz Ltd; 1989.
  • Del Rosso JQ, Kircik LH. The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician? J Drugs Dermatol. 2013;12(8 Suppl):S109–S115.
  • Kim YJ, Lee SB, Lee HB. Oleic acid enhances keratinocytes differentiation via the upregulation of miR-203 in human epidermal keratinocytes. J Cosmet Dermatol. 2019;18(1):383–389. doi: 10.1111/jocd.12543.
  • Lovászi M, Mattii M, Eyerich K, et al. Sebum lipids influence macrophage polarization and activation. Br J Dermatol. 2017;177(6):1671–1682. doi: 10.1111/bjd.15754.
  • Nakatsuji T, Kao MC, Zhang L, et al. Sebum free fatty acids enhance the innate immune defense of human sebocytes by upregulating beta-defensin-2 expression. J Invest Dermatol. 2010;130(4):985–994. doi: 10.1038/jid.2009.384.
  • Li X, He C, Chen Z, et al. A review of the role of sebum in the mechanism of acne pathogenesis. J Cosmet Dermatol. 2017;16(2):168–173. doi: 10.1111/jocd.12345.
  • Makrantonaki E, Ganceviciene R, Zouboulis C. An update on the role of the sebaceous gland in the pathogenesis of acne. Dermatoendocrinol. 2011;3(1):41–49. doi: 10.4161/derm.3.1.13900.
  • Kligman AM, Wheatley VR, Mills OH. Comedogenicity of human sebum. Arch Dermatol. 1970;102(3):267–275. doi: 10.1001/archderm.1970.04000090029005.
  • Kligman AM, Katz AG. Pathogenesis of acne vulgaris. I. Comedogenic properties of human sebum in external ear canal of the rabbit. Arch Dermatol. 1968;98(1):53–57. doi: 10.1001/archderm.1968.01610130059013.
  • Li WH, Zhang Q, Flach CR, et al. In vitro modeling of unsaturated free fatty acid-mediated tissue impairments seen in acne lesions. Arch Dermatol Res. 2017;309(7):529–540. doi: 10.1007/s00403-017-1747-y.
  • Mohiuddin AK. A comprehensive review of acne vulgaris. CRDOA. 2019;6(2):1–34. doi: 10.15226/2378-1726/6/2/00186.
  • Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190–1192. doi: 10.1126/science.1171700.
  • Borrel V, Gannesen AV, Barreau M, et al. Adaptation of acneic and non acneic strains of Cutibacterium acnes to sebum-like environment. MicrobiologyOpen. 2019;8(9):e00841. doi: 10.1002/mbo3.841.
  • Josse G, Mias C, Le Digabel J, et al. High bacterial colonization and lipase activity in microcomedones. Exp Dermatol. 2020;29(2):168–176. doi: 10.1111/exd.14069.
  • Clayton RW, Langan EA, Ansell DM, et al. Neuroendocrinology and neurobiology of sebaceous glands. Biol Rev Camb Philos Soc. 2020;95(3):592–624. doi: 10.1111/brv.12579.
  • Harris HH, Downing DT, Stewart ME, et al. Sustainable rates of sebum secretion in acne patients and matched normal control subjects. J Am Acad Dermatol. 1983;8(2):200–203. doi: 10.1016/s0190-9622(83)70023-x.
  • Piérard GE, Piérard-Franchimont C, Lê T. Seborrhoea in acne-prone and acne-free patients. Dermatologica. 1987;175(1):5–9. doi: 10.1159/000248774.
  • Piérard-Franchimont C, Piérard GE, Saint-Léger D, et al. Comparison of the kinetics of sebum secretion in young women with and without acne. Dermatologica. 1991;183(2):120–122. doi: 10.1159/000247650.
  • Çölgeçen E, Özyurt K, Ferahbaş Kesikoğlu A. Ferahbas kesikoglu A. The effect of systemic isotretinoin treatment on skin biophysicalparameters among patients with acne vulgaris. Turk J Med Sci. 2016;46(6):1641–1644. doi: 10.3906/sag-1507-31.
  • Hughes BR, Cunliffe WJ. A prospective study of the effect of isotretinoin on the follicular reservoir and sustainable sebum excretion rate in patients with acne. Arch Dermatol. 1994;130(3):315–318. doi: 10.1001/archderm.1994.01690030047007.
  • Andreadi A, Muscoli S, Tajmir R, et al. Insulin resistance and acne: the role of metformin as alternative therapy in men. Pharmaceuticals (Basel). 2022;16(1):27. doi: 10.3390/ph16010027.
  • Hay JB, Hodgins MB. Metabolism of androgens by human skin in acne. Br J Dermatol. 1974;91(2):123–133. doi: 10.1111/j.1365-2133.1974.tb15857.x.
  • Hay JB, Hodgins MB. Distribution of androgen metabolizing enzymes in isolated tissues of human forehead and axillary skin. J Endocrinol. 1978;79(1):29–39. doi: 10.1677/joe.0.0790029.
  • Tan MH, Li J, Xu HE, et al. Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin. 2015;36(1):3–23. doi: 10.1038/aps.2014.18.
  • Burkhart CG, Burkhart CN. Expanding the microcomedone theory and acne therapeutics: propionibacterium acnes biofilm produces biological glue that holds corneocytes together to form plug. J Am Acad Dermatol. 2007;57(4):722–724. doi: 10.1016/j.jaad.2007.05.013.
  • Platsidaki E, Dessinioti C. Recent advances in understanding Propionibacterium acnes (Cutibacterium acnes) in acne. F1000Res. 2018;7:1953. doi: 10.12688/f1000research.15659.1.
  • Krause K, Schnitger A, Fimmel S, et al. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Horm Metab Res. 2007;39(2):166–170. doi: 10.1055/s-2007-961811.
  • Wang Y, Hata TR, Tong YL, et al. The anti-inflammatory activities of Propionibacterium acnes camp factor-targeted acne vaccines. J Invest Dermatol. 2018;138(11):2355–2364. doi: 10.1016/j.jid.2018.05.032.
  • Stewart ME, Grahek MO, Cambier LS, et al. Dilutional effect of increased sebaceous gland activity on the proportion of linoleic acid in sebaceous wax esters and in epidermal acylceramides. J Invest Dermatol. 1986;87(6):733–736. doi: 10.1111/1523-1747.ep12456856.
  • Perisho K, Wertz PW, Madison KC, et al. Fatty acids of acylceramides from comedones and from the skin surface of acne patients and control subjects. J Invest Dermatol. 1988;90(3):350–353. doi: 10.1111/1523-1747.ep12456327.
  • Elias PM, Brown BE, Ziboh VA. The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol. 1980;74(4):230–233. doi: 10.1111/1523-1747.ep12541775.
  • Simard M, Tremblay A, Morin S, et al. α-Linolenic acid and linoleic acid modulate the lipidome and the skin barrier of a tissue-engineered skin model. Acta Biomater. 2022;140:261–274. doi: 10.1016/j.actbio.2021.11.021.
  • Rosenfield RL, Kentsis A, Deplewski D, et al. Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Invest Dermatol. 1999;112(2):226–232. doi: 10.1046/j.1523-1747.1999.00487.x.
  • Trivedi NR, Cong Z, Nelson AM, et al. Peroxisome proliferator-activated receptors increase human sebum production. J Invest Dermatol. 2006;126(9):2002–2009. doi: 10.1038/sj.jid.5700336.
  • Mastrofrancesco A, Ottaviani M, Cardinali G, et al. Pharmacological PPARγ modulation regulates sebogenesis and inflammation in SZ95 human sebocytes. Biochem Pharmacol. 2017;138:96–106. doi: 10.1016/j.bcp.2017.04.030.
  • Alestas T, Ganceviciene R, Fimmel S, et al. Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med (Berl). 2006;84(1):75–87. doi: 10.1007/s00109-005-0715-8.
  • Dozsa A, Dezso B, Toth BI, et al. PPARγ-mediated and arachidonic acid-dependent signaling is involved in differentiation and lipid production of human sebocytes. J Invest Dermatol. 2014;134(4):910–920. doi: 10.1038/jid.2013.413.
  • Ge L, Gordon JS, Hsuan C, et al. Identification of the delta-6 desaturase of human sebaceous glands: expression and enzyme activity. J Invest Dermatol. 2003;120(5):707–714. doi: 10.1046/j.1523-1747.2003.12123.x.
  • Drake DR, Brogden KA, Dawson DV, et al. Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res. 2008;49(1):4–11. doi: 10.1194/jlr.R700016-JLR200.
  • Fischer CL, Drake DR, Dawson DV, et al. Antibacterial activity of sphingoid bases and fatty acids against gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 2012;56(3):1157–1161. doi: 10.1128/AAC.05151-11.
  • Okoro OE, Adenle A, Ludovici M, et al. Lipidomics of facial sebum in the comparison between acne and non-acne adolescents with dark skin. Sci Rep. 2021;11(1):16591. doi: 10.1038/s41598-021-96043-x.
  • Ottaviani M, Alestas T, Flori E, et al. Peroxidated squalene induces the production of inflammatory mediators in HaCaT keratinocytes: a possible role in acne vulgaris. J Invest Dermatol. 2006;126(11):2430–2437. doi: 10.1038/sj.jid.5700434.
  • Youn SW. The role of facial sebum secretion in acne pathogenesis: facts and controversies. Clin Dermatol. 2010;28(1):8–11. doi: 10.1016/j.clindermatol.2009.03.011.
  • Spigariolo CB, Giacalone S, Nazzaro G. Maskne: the epidemic within the pandemic: from diagnosis to therapy. J Clin Med. 2022;11(3):618. doi: 10.3390/jcm11030618.
  • Park SG, Kim YD, Kim JJ, et al. Two possible classifications of facial skin type by two parameters in korean women: sebum excretion rate (SER) and skin surface relief (SSR). Skin Res Technol. 1999;5(3):189–194. doi: 10.1111/j.1600-0846.1999.tb00130.x.
  • Choi CW, Choi JW, Park KC, et al. Facial sebum affects the development of acne, especially the distribution of inflammatory acne. J Eur Acad Dermatol Venereol. 2013;27(3):301–306. doi: 10.1111/j.1468-3083.2011.04384.x.
  • Kim MK, Choi SY, Byun HJ, et al. Comparison of sebum secretion, skin type, pH in humans with and without acne. Arch Dermatol Res. 2006;298(3):113–119. doi: 10.1007/s00403-006-0666-0.
  • Youn SH, Choi CW, Choi JW, et al. Novel facial cosmetic area ‘O zone’ shows unique characteristics in sebum excretion and acne lesion distribution. Skin Res Technol. 2014;20(2):164–169. doi: 10.1111/srt.12101.
  • Youn SW, Park ES, Lee DH, et al. Does facial sebum excretion really affect the development of acne? Br J Dermatol. 2005;153(5):919–924. doi: 10.1111/j.1365-2133.2005.06794.x.
  • Lopez S, Le Fur I, Morizot F, et al. Transepidermal water loss, temperature and sebum levels on women’s facial skin follow characteristic patterns. Skin Res Technol. 2000;6(1):31–36. doi: 10.1034/j.1600-0846.2000.006001031.x.
  • Le Fur I, Lopez S, Morizot F, et al. Comparison of cheek and forehead regions by bioengineering methods in women with different self-reported “cosmetic skin types”. Skin Res Technol. 2006;5(3):182–188. doi: 10.1111/j.1600-0846.1999.tb00129.x.
  • ORTHO TRI-CYCLEN® tablets (norgestimate/ethinyl estradiol) [prescribing information]. Tulsa (OK): Physicians Total Care, Inc.; 2012.
  • ESTROSTEP® Fe (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets) [prescribing information]. Irvine (CA): Allergan USA, Inc.; 2017.
  • Layton AM, Eady EA, Whitehouse H, et al. Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review. Am J Clin Dermatol. 2017;18(2):169–191. doi: 10.1007/s40257-016-0245-x.
  • WINLEVI® (clascoterone) cream, for topical use [prescribing information]. Cranbury (NJ): Sun Pharmaceutical Industries, Inc.; 2022.
  • Rosette C, Rosette N, Mazzetti A, et al. Cortexolone 17α-propionate (clascoterone) is an androgen receptor antagonist in dermal papilla cells in vitro. J Drugs Dermatol. 2019;18(2):197–201.
  • Rosette C, Agan FJ, Mazzetti A, et al. Cortexolone 17α-propionate (clascoterone) is a novel androgen receptor antagonist that inhibits production of lipids and inflammatory cytokines from sebocytes in vitro. J Drugs Dermatol. 2019;18(5):412–418.
  • Layton AM, Alexis A, Baldwin H, et al. The personalized acne treatment tool – recommendations to facilitate a patient-centered approach to acne management from the personalizing acne: consensus of experts. JAAD Int. 2023;12:60–69. doi: 10.1016/j.jdin.2023.03.013.
  • Han JJ, Faletsky A, Barbieri JS, et al. New acne therapies and updates on use of spironolactone and isotretinoin: a narrative review. Dermatol Ther. 2021;11(1):79–91. doi: 10.1007/s13555-020-00481-w.
  • Afzali BM, Yaghoobi E, Yaghoobi R, et al. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial. J Dermatolog Treat. 2012;23(1):21–25. doi: 10.3109/09546634.2010.488260.
  • Bhatt S, Kothari R, Tripathy DM, et al. Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials. Expert Opin Emerg Drugs. 2022;27(3):241–261. doi: 10.1080/14728214.2022.2110239.
  • Picardo M, Cardinali C, La Placa M, et al. Efficacy and safety of N-acetyl-GED-0507-34-LEVO gel in patients with moderate-to severe facial acne vulgaris: a phase IIb randomized double-blind, vehicle-controlled trial. Br J Dermatol. 2022;187(4):507–514. doi: 10.1111/bjd.21663.
  • Bissonnette R, Poulin Y, Drew J, et al. Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: a phase IIa, multicenter, randomized, vehicle-controlled study. J Am Acad Dermatol. 2017;76(1):33–39. doi: 10.1016/j.jaad.2016.08.053.
  • Majeed M, Majeed S, Nagabhushanam K, et al. Novel topical application of a postbiotic, lactosporin®, in mild to moderate acne: a randomized, comparative clinical study to evaluate its efficacy, tolerability and safety. Cosmetics. 2020;7(3):70. doi: 10.3390/cosmetics7030070.
  • Jung JY, Kwon HH, Hong JS, et al. Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial. Acta Derm Venereol. 2014;94(5):521–525. doi: 10.2340/00015555-1802.
  • Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(3 Suppl):S200–S210. doi: 10.1067/s0190-9622(03)01154-x.